Shanghai Henlius Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	5,798	5,724	5,395	3,215	1,682	587.59
Revenue Growth (YoY)	2.79%	6.11%	67.82%	91.07%	186.34%	546.20%
Cost of Revenue	1,405	1,540	1,476	844.62	522.75	182.12
Gross Profit	4,393	4,185	3,919	2,370	1,160	405.47
Selling, General & Admin	2,401	2,288	2,138	1,403	800.87	436.29
Research & Development	1,138	1,035	1,119	1,395	1,024	894.14
Operating Expenses	3,537	3,318	3,266	2,999	1,825	1,330
Operating Income	855.95	866.5	652.95	-628.53	-665.25	-924.95
Interest Expense	-114.43	-122.89	-110.54	-105.67	-84.82	-43.71
Interest & Investment Income	20.88	21.7	8.15	3.57	2.69	7.4
Currency Exchange Gain (Loss)	4.57	8.14	-1.42	32.92	-	-
Other Non Operating Income (Expenses)	76.93	72.43	20.44	202.97	-209.36	-32.29
EBT Excluding Unusual Items	843.9	845.88	569.58	-494.73	-956.74	-993.54
Gain (Loss) on Sale of Investments	-	-	-	-199.15	-	-
Pretax Income	843.9	845.88	569.58	-693.89	-956.74	-993.54
Income Tax Expense	19.6	25.41	23.56	1.37	27.31	-
Earnings From Continuing Operations	824.3	820.47	546.02	-695.26	-984.05	-993.54
Net Income	824.3	820.47	546.02	-695.26	-984.05	-993.54
Net Income to Common	824.3	820.47	546.02	-695.26	-984.05	-993.54
Net Income Growth	19.06%	50.26%	-	-	-	-
Shares Outstanding (Basic)	543	543	543	542	539	530
Shares Outstanding (Diluted)	543	543	543	542	539	530
Shares Change (YoY)	-0.00%	0.02%	0.25%	0.59%	1.75%	6.52%
EPS (Basic)	1.52	1.51	1.01	-1.28	-1.83	-1.88
EPS (Diluted)	1.52	1.51	1.00	-1.28	-1.83	-1.88
EPS Growth	19.43%	50.96%	-	-	-	-
Free Cash Flow	1,528	1,078	574.25	396.65	-370.04	-1,167
Free Cash Flow Per Share	2.81	1.98	1.06	0.73	-0.69	-2.20
Gross Margin	75.77%	73.10%	72.64%	73.73%	68.93%	69.01%
Operating Margin	14.76%	15.14%	12.10%	-19.55%	-39.54%	-157.41%
Profit Margin	14.22%	14.33%	10.12%	-21.63%	-58.49%	-169.09%
Free Cash Flow Margin	26.35%	18.83%	10.64%	12.34%	-21.99%	-198.54%
EBITDA	1,197	1,162	932.58	-419.93	-518.3	-831.47
EBITDA Margin	20.64%	20.29%	17.29%	-13.06%	-30.80%	-141.50%
D&A For EBITDA	341	295.29	279.63	208.6	146.95	93.49
EBIT	855.95	866.5	652.95	-628.53	-665.25	-924.95
EBIT Margin	14.76%	15.14%	12.10%	-19.55%	-39.54%	-157.41%
Effective Tax Rate	2.32%	3.00%	4.14%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.